Loco-regional treatment with temozolomide-loaded thermogels prevents glioblastoma recurrences in orthotopic human xenograft models
Glioblastoma multiforme (GBM) is the most aggressive primary tumor of the central nervous system and the diagnosis is often dismal. GBM pharmacological treatment is strongly limited by its intracranial location beyond the blood-brain barrier (BBB). While Temozolomide (TMZ) exhibits the best clinical...
שמור ב:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | אנגלית |
יצא לאור: |
2023
|
גישה מקוונת: | https://doi.org/10.1038/s41598-023-31811-5 https://www.nature.com/articles/s41598-023-31811-5.pdf |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|